These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5810219)

  • 21. BINDING CAPABILITY OF VARIOUS SULFONAMIDES TO SERUMS OF DIFFERENT ANIMAL SPECIES.
    GENAZZANI E; PAGNINI G
    Am J Vet Res; 1963 Nov; 24():1212-6. PubMed ID: 14081457
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug-induced hemolytic anemia.
    de LEEUW N; SHAPIRO L; LOWENSTEIN L
    Ann Intern Med; 1963 Apr; 58():592-607. PubMed ID: 13929214
    [No Abstract]   [Full Text] [Related]  

  • 23. An automated method for the determination of sulfonamides in plasma.
    Falk HB; Kelly RG
    Clin Chem; 1965 Dec; 11(12):1045-50. PubMed ID: 5898037
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hydrolysis of N4-substituted sulfonamides depending on the pH value].
    Funk KF; Oelssner W
    Pharmazie; 1966 Aug; 21(8):470-3. PubMed ID: 5992578
    [No Abstract]   [Full Text] [Related]  

  • 25. Sulfonamides competing with bilirubin for conjugation to albumin.
    Josephson B; Furst P
    Scand J Clin Lab Invest; 1966; 18(1):51-63. PubMed ID: 5918673
    [No Abstract]   [Full Text] [Related]  

  • 26. QUANTITATIVE ANALYSIS OF SULFONAMIDE MIXTURES BY THIN-LAYER CHROMATOGRAPHY.
    BICAN FISTER T; KAJGANOVIC V
    J Chromatogr; 1964 Dec; 16():503-9. PubMed ID: 14265873
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of the molecular structure of closely related N1-substituents of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and renal clearance related to the structure of sulfadiazine, sulfamerazine and sulfadimidine.
    Vree TB; Hekster YA; Tijhuis MW; Baakman M; Janssen TJ; Termond EF
    Pharm Weekbl Sci; 1983 Apr; 5(2):49-56. PubMed ID: 6866714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The N-oxides of some sulfonamide compounds.
    Bobrański B; Mordarski M; Pelczarska A; Pomorski J
    Arch Immunol Ther Exp (Warsz); 1968; 16(5):804-16. PubMed ID: 4974587
    [No Abstract]   [Full Text] [Related]  

  • 29. [Significance of acid stability of sulfonamides for the determination of their N4-metabolites].
    Reimerdes EH; Seydel JK
    Arzneimittelforschung; 1969 Nov; 19(11):1863-8. PubMed ID: 5395657
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on anticoccidial agents. 13. Synthesis and anticoccidial activity of nitropyridine-2- and -3-sulfonamides and derivatives.
    Morisawa Y; Kataoka M; Nagahori H; Sakamoto T; Kitano N; Kusano K; Sato K
    J Med Chem; 1980 Dec; 23(12):1376-80. PubMed ID: 7452692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the mechanism of the binding of sulfonamides to bovine serum albumin.
    Jardetzky O; Wade-Jardetzky NG
    Mol Pharmacol; 1965 Nov; 1(3):214-30. PubMed ID: 5842823
    [No Abstract]   [Full Text] [Related]  

  • 32. Sulphonamide investigations; the activity in vitro of sulphathiazole, sulphadiazine, sulphamerazine, sulphapyridine, sulphamezathine and sulphanilamide on some common animal pathogens.
    MACLAY MH; SLAVIN G
    J Comp Pathol Ther; 1947 Jul; 57(3):218-22. PubMed ID: 20265765
    [No Abstract]   [Full Text] [Related]  

  • 33. Sulphonamide investigations; the absorption and excretion in dairy cows of sulphapyridine, sulphamexathine, sulphamerazine, sulphadiazine, sulphathiazole and sulphapyrazine.
    MACLAY MH; SLAVIN G
    Vet Rec; 1947 Jun; 59(24):313-7. PubMed ID: 20255031
    [No Abstract]   [Full Text] [Related]  

  • 34. [Increase in albumin binding of promazine, depending on other drugs].
    Krieglstein J; Franz JW; Jähnchen E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):261. PubMed ID: 4242407
    [No Abstract]   [Full Text] [Related]  

  • 35. [Investigations on mass spectrometry. IV. Sulfonamides substituted with diazine nuclei].
    Cambon A; Guedj R; Robert D; Soyfer JC; Azzaro M
    Bull Soc Chim Fr; 1970 Feb; 2():567-71. PubMed ID: 5418422
    [No Abstract]   [Full Text] [Related]  

  • 36. Warning against prolonged-action sulfonamides.
    Med Lett Drugs Ther; 1966 Feb; 8(4):13-4. PubMed ID: 5907884
    [No Abstract]   [Full Text] [Related]  

  • 37. [ISOLATION OF BETA-N4-GLUCOSIDASE FROM RABBIT PLASMA AND EXAMINATION OF ITS PROPERTIES WITH SULFONAMIDE-BETA-N4-GLUCOSIDES].
    TOTH B; KELENTEY B; CZINDER K; VALYI-NAGY T
    Biochem Pharmacol; 1964 Jun; 13():881-91. PubMed ID: 14186837
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-protein binding. IV. Modulation of binding. Increasing activity of sulfonamides with displacing agents: a review.
    Anton AH
    Ann N Y Acad Sci; 1973 Nov; 226():273-92. PubMed ID: 4588442
    [No Abstract]   [Full Text] [Related]  

  • 39. MANAGEMENT ACUTE PYELONEPHRITIS.
    SMYTHE CM
    Mod Treat; 1964 Jan; 1():63-77. PubMed ID: 14161717
    [No Abstract]   [Full Text] [Related]  

  • 40. Kinetic and thermodynamic aspects of in vitro interphase transfer of sulfonamides. I. Influence of methyl group substitution on transfer of unionized sulfonamides.
    Schumacher GE; Nagwekar JB
    J Pharm Sci; 1974 Feb; 63(2):240-4. PubMed ID: 4813246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.